Author:
Poplin Elizabeth A.,Liu P.Y.,Delmore James E.,Wilczynski Sharon,Moore Dennis F.,Potkul Ronald K.,Fine Bruce A.,Hannigan Edward V.,Alberts David S.
Subject
Obstetrics and Gynaecology,Oncology
Reference35 articles.
1. High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group Study;Lentz;J Clin Oncol,1996
2. A randomized trial of medroxyprogesterone acetate (MPA) 200 mg. vs 1,000 mg. daily in advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group Study;Thigpen;ASCO,1991
3. Treatment of advanced endometrial adenocarcinoma with cis-dichlorodiammine platinum (II) after intensive prior therapy;Deppe;Gynecol Oncol,1980
4. Randomized phase II study of cisplatin and combination of cyclophosphamide–doxorubicin–cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinoma;Edmonson;Gynecol Oncol,1987
5. Use of cisplatin, doxorubicin and cyclophosophamide to treat advanced and recurrent adenocarcinoma of endometrium;Hancock;Cancer Treat Rep,1986
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献